India approves AstraZeneca vaccine as company still working on jab’s efficacy of at least 62% after disappointing trial results

Follow RT on India has approved AstraZeneca’s Covid-19 jab for emergency use, despite trials showing its efficacy to be 62 percent with two full shots. AstraZeneca claims to have discovered a new “winning formula,” but hasn’t revealed it yet. India’s information minister, Prakash Javadekar, announced on Saturday that the coronavirus…

read more